Key facts
- Artedrone’s last known valuation is $11.4M (Dec 2025).
- It has raised $22.6M; the latest was Later Stage VC in May 2025.
- Status: Acquired/Merged (Operating Subsidiary).
- ·Watchlist + deal alerts for Artedrone
- ·The full record, as it builds
Funding rounds
No funding rounds for Artedrone are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Artedrone
Developer of autonomous robotics designed for stroke treatment and interventional neuroradiology. The company system utilizes therapeutic microrobots controlled by a magnetic guidance device, enabling healthcare providers to perform mechanical thrombectomy with reduced expertise requirements, expand access to life-saving stroke interventions, improve procedural efficiency, and address limitations in specialist availability.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2017
- Employees
- 10
- Website
- artedrone.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Artedrone doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Artedrone shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Artedrone in its N-PORT filings yet. We sweep new filings monthly.